-
EXPLICITNESS OF BROADER VALUE ELEMENTS IN ORPHAN DRUG HEALTH TECHNOLOGY ASSESSMENT (HTA): A 12-COUNTRY COMPARATIVE ASSESSMENT IN EUROPE
Aug 11, 2026, 17:16 PM -
GLOBAL HETEROGENEITIES OF TRUST IN SCIENCE, SOCIAL CONSENSUS, AND VACCINE ACCEPTANCE: EVIDENCE FROM THE WELLCOME GLOBAL MONITOR DATA
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGY, PROGNOSIS, AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN HER2-POSITIVE, RAS WILD-TYPE (WT), METASTATIC COLORECTAL CANCER (MCRC): A LITERATURE REVIEW AND QUALITATIVE SYNTHESIS
Aug 11, 2026, 17:16 PM -
IRON-AI - IRON REPLACEMENT OPTIONS NAVIGATOR: AN R/SHINY-BASED ARTIFICIAL INTELLIGENCE TOOL TO SUPPORT DECISION-MAKING IN INTRAVENOUS IRON THERAPY
Aug 11, 2026, 17:16 PM -
REAL-WORLD POLICY IMPACT OF A TUMOR-AGNOSTIC CLINICAL GENE PANEL FOR ADVANCED CANCERS
Aug 11, 2026, 17:16 PM -
EVALUATING THE IMPACT OF COENZYME Q10 ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE: A PATIENT-REPORTED OUTCOMES STUDY
Aug 11, 2026, 17:16 PM -
AN AUDIT OF CLINICAL EFFECTIVENESS EVIDENCE USED IN NICE HEALTH TECHNOLOGY ASSESSMENT SUBMISSIONS FOR MULTIPLE SCLEROSIS
Aug 11, 2026, 17:16 PM -
STATE OF MIND: A REVIEW OF EUROPEAN DEMENTIA GUIDELINES IN PRIMARY CARE
Aug 11, 2026, 17:16 PM -
FATIGUE AS A LEADING PATIENT-REPORTED DISEASE BURDEN DRIVER ACROSS MULTIPLE SCLEROSIS SUBTYPES: A MULTINATIONAL QUALITATIVE STUDY
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF A VIDEO-BASED EXERCISE PROGRAMME FOR FALLS PREVENTION AMONG OLDER ADULTS: A QUASI-EXPERIMENTAL STUDY
Aug 11, 2026, 17:16 PM -
OBSERVANCE OF ANTIFIBROTIC TREATMENT IN THE FRENCH OPALE SUPPORT PROGRAM FOR PATIENTS WITH PULMONARY FIBROSIS
Aug 11, 2026, 17:16 PM -
HEALTHCARE UTILIZATION FOR CERVICAL CANCER IN BRAZIL: A NATIONAL ANALYSIS OF OUTPATIENT AND INPATIENT CARE
Aug 11, 2026, 17:16 PM -
ENHANCING IMMUNIZATION COVERAGE MONITORING AFTER RECOMMENDATION CHANGES: THE VALUE AND CHALLENGES OF SURVEY-BASED PRIMARY DATA
Aug 11, 2026, 17:16 PM -
ECONOMICEVALUATION OF TISLELIZUMAB IN COMBINATION WITH GEMCITABINE AND CISPLATIN AS FIRST-LINETREATMENT IN PATIENTS WITH RECURRENT OR METASTATIC NASOPHARYNGEAL CANCER IN THAILAND
Aug 11, 2026, 17:16 PM -
FOOD NOISE DURING GLUCAGON-LIKE PEPTIDE-1 (GLP-1) MAINTENANCE: A SOCIAL MEDIA LISTENING ANALYSIS OF UK PATIENT COMMUNITIES
Aug 11, 2026, 17:16 PM -
AGENTIC ARTIFICIAL INTELLIGENCE AS A CO-DEVELOPER OF HEALTH ECONOMIC MODELS: APPLICATION TO A COST-EFFECTIVENESS ANALYSIS IN ADULT ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)
Aug 11, 2026, 17:16 PM -
FINANCIAL SOLUTIONS - PATIENT PAYMENT MODELS AND ALTERNATIVE FORMS OF FINANCING
Aug 11, 2026, 17:16 PM -
CAREGIVER BURDEN IN HUNTINGTON'S DISEASE: IMPACT ON QUALITY OF LIFE AND WORK PRODUCTIVITY IN THE UK (HDBOI STUDY)
Aug 11, 2026, 17:16 PM -
THE COMBINED ANALYSIS OF UNCERTAINTY AND PATIENT HETEROGENEITY WHEN ASSESSING TREATMENT SEQUENCES IN RHEUMATOID ARTHRITIS
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILISATION FOR INDIVIDUALS WITH TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: RESULTS FROM A JAPANESE ELECTRONIC HEALTH RECORD DATABASE
Aug 11, 2026, 17:16 PM
